Contact this trialFirst, we need to learn more about you.
Alkylating agents
Cyclophosphamide + Bortezomib + Abatacept for Graft-versus-Host Disease
Recruiting3 awardsPhase 1 & 2
New York, New York
This trial is for adult patients with blood cancers who are undergoing a stem cell transplant from a matched donor. The patients will receive standard care, as well as investigational drugs to help prevent GvHD.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.